Anderson B, Khaper N, Dhalla A K, Singal P K
Institute of Cardiovascular Sciences, St Boniface General Hospital Research Centre, Winnipeg, Manitoba.
Can J Cardiol. 1996 Oct;12(10):1099-104.
Captopril, an angiotensin-converting enzyme (ACE) inhibitor, is known to modulate ischemia-reperfusion injury in the isolated hearts. This study was designed to examine the involvement of anti-free radical mechanisms in this protection.
Isolated perfused rat hearts were subjected to 60 mins of global ischemia and 30 mins of reperfusion with or without captopril (100 mumol/L). Myocardial resting tension and contractile force were recorded. At the end of reperfusion, hearts were analyzed for the activities of antioxidant enzymes, superoxide dismutase, glutathione peroxidase and catalase, as well as for the extent of lipid peroxidation. Another potent ACE inhibitor, enalapril (100 mumol/L) was used for comparison.
Captopril significantly improved the recovery of contractile function as well as attenuated the rise in resting tension in the ischemic-reperfused hearts as compared to the control. Captopril-exposed ischemic-reperfused hearts showed an increase in the activity of superoxide dismutase with no change in glutathione peroxidase and catalase enzyme activities. Lipid peroxidation at the end of reperfusion was significantly attenuated in the captopril-exposed hearts compared to the control. Enalapril had no protective effect against ischemia-reperfusion induced contractile failure or rise in resting force.
These results suggest that cardioprotection by captopril, against ischemia-reperfusion injury, may involve an anti-free radical mechanism independent of its ACE inhibition property.
卡托普利是一种血管紧张素转换酶(ACE)抑制剂,已知其可调节离体心脏的缺血再灌注损伤。本研究旨在探讨抗自由基机制在这种保护作用中的参与情况。
将离体灌注的大鼠心脏进行60分钟的全心缺血和30分钟的再灌注,再灌注时分别加入或不加入卡托普利(100μmol/L)。记录心肌静息张力和收缩力。再灌注结束时,分析心脏中抗氧化酶超氧化物歧化酶、谷胱甘肽过氧化物酶和过氧化氢酶的活性,以及脂质过氧化程度。另一种强效ACE抑制剂依那普利(100μmol/L)用于比较。
与对照组相比,卡托普利显著改善了缺血再灌注心脏收缩功能的恢复,并减轻了静息张力的升高。暴露于卡托普利的缺血再灌注心脏中超氧化物歧化酶活性增加,而谷胱甘肽过氧化物酶和过氧化氢酶活性无变化。与对照组相比,暴露于卡托普利的心脏在再灌注结束时脂质过氧化显著减轻。依那普利对缺血再灌注诱导的收缩功能衰竭或静息力升高没有保护作用。
这些结果表明,卡托普利对缺血再灌注损伤的心脏保护作用可能涉及一种独立于其ACE抑制特性的抗自由基机制。